Prof. Ed Iacobucci publishes report on IP protection for pharmaceutical companies

(May 30, 2011) Prof. Edward Iacobucci, Osler Chair in Business Law, has prepared a report that argues that Intellectual Property (IP) protection for pharmaceutical companies in Canada is already stronger than that in any other industrial sector in Canada, and is in many ways stronger than pharmaceutical IP in the European Union and United States.

The report, Innovation for a Better Tomorrow: A Critique, was prepared for the Canadian Generic Pharmaceutical Association in response to a report by the Canadian Intellectual Property Council (CIPC) of the Canadian Chamber of Commerce that claimed that Canada's IP regime lags behind that of international competitors.

• Read the full press release for Prof. Iacobucci's report
• Read the full report (PDF)
• Read Michael Geist's column about the report in the Toronto Star ("EU/big pharma deal would raise health care costs," June 3, 2011).